Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for CVRx, Inc. (CVRX : NSDQ)

• Company Description    CVRx Inc. is a commercial-stage medical device company. It focused on developing, manufacturing and commercializing neuromodulation solutions for patients with cardiovascular diseases. CVRx Inc. is headquartered in Minneapolis, MN. Number of Employees: 223

• Price / Volume Information    Yesterday's Closing Price: $6.11 Daily Weekly Monthly 20 Day Moving Average: 375,806 shares Shares Outstanding: 26.54 (millions) Market Capitalization: $162.13 (millions) Beta: 0.90 52 Week High: $11.30 52 Week Low: $4.37 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -20.03% -23.93% 12 Week -24.19% -29.92% Year To Date -13.94% -21.40%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 9201 WEST BROADWAY AVENUE SUITE 650 - MINNEAPOLIS,MN 55445 USA ph: 763-416-2840 fax: 763-416-2841 ir@cvrx.com http://www.cvrx.com

• General Corporate Information    Officers Kevin Hykes - Chief Executive Officer and President Jared Oasheim - Chief Financial Officer Kevin Ballinger - Director Mitch Hill - Director Mudit Jain - Director Peer Information CVRx, Inc. (ABMD) CVRx, Inc. (DMDS) CVRx, Inc. (CPWY.) CVRx, Inc. (EQUR) CVRx, Inc. (ECIA) CVRx, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 126638105 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/03/26 Share - Related Items Shares Outstanding: 26.54 Most Recent Split Date: (:1) Beta: 0.90 Market Capitalization: $162.13 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.52 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.89 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/03/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 5.57 Price/Cash Flow: - Price / Sales: 2.74 EPS Growth vs. Year Ago Period: 5.66% vs. Previous Quarter: -8.70% Sales Growth vs. Year Ago Period: 19.61% vs. Previous Quarter: -7.83% ROE 03/31/26 - -120.76 12/31/25 - -99.32 09/30/25 - -84.45 ROA 03/31/26 - -48.38 12/31/25 - -45.83 09/30/25 - -42.13 Current Ratio 03/31/26 - 10.20 12/31/25 - 7.63 09/30/25 - 9.62 Quick Ratio 03/31/26 - 8.89 12/31/25 - 6.72 09/30/25 - 8.60 Operating Margin 03/31/26 - -89.14 12/31/25 - -94.10 09/30/25 - -92.95 Net Margin 03/31/26 - -89.14 12/31/25 - -94.10 09/30/25 - -92.95 Pre-Tax Margin 03/31/26 - -89.17 12/31/25 - -94.13 09/30/25 - -93.10 Book Value 03/31/26 - 1.10 12/31/25 - 1.50 09/30/25 - 1.83 Inventory Turnover 03/31/26 - 0.68 12/31/25 - 0.71 09/30/25 - 0.74 Debt-to-Equity 03/31/26 - 2.01 12/31/25 - 1.26 09/30/25 - 1.03 Debt-to-Capital 03/31/26 - 66.77 12/31/25 - 55.74 09/30/25 - 50.72

Powered by Zacks Investment Research ©